180 related articles for article (PubMed ID: 33794268)
1. Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.
Biller LH; Horiguchi M; Uno H; Ukaegbu C; Syngal S; Yurgelun MB
Gastroenterology; 2021 Jul; 161(1):143-150.e4. PubMed ID: 33794268
[TBL] [Abstract][Full Text] [Related]
2. Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome.
Wischhusen JW; Ukaegbu C; Dhingra TG; Uno H; Kastrinos F; Syngal S; Yurgelun MB
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):193-199. PubMed ID: 31615790
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
4. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
6. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
8. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
International Mismatch Repair Consortium
Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
[TBL] [Abstract][Full Text] [Related]
9. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort.
Zhong CS; Horiguchi M; Uno H; Ukaegbu C; Chittenden A; LeBoeuf NR; Syngal S; Nambudiri VE; Yurgelun MB
J Am Acad Dermatol; 2023 Jun; 88(6):1282-1290. PubMed ID: 36773823
[TBL] [Abstract][Full Text] [Related]
10. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.
Fu L; Sheng JQ; Li XO; Jin P; Mu H; Han M; Huang JS; Sun ZQ; Li AQ; Wu ZT; Li SR
Cell Oncol (Dordr); 2013 Jun; 36(3):225-31. PubMed ID: 23640085
[TBL] [Abstract][Full Text] [Related]
13. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
14. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
[TBL] [Abstract][Full Text] [Related]
15. The contribution of Lynch syndrome to early onset malignancy in Ireland.
Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
[TBL] [Abstract][Full Text] [Related]
16. Success of referral to genetic counseling after positive lynch syndrome screening test.
Irons RF; Contino KM; Horte JJ; Levin B; Mattie KD; Wight M; Kwiatt ME; Behling KC; Edmonston TB; McClane SJ
Int J Colorectal Dis; 2017 Sep; 32(9):1345-1348. PubMed ID: 28664346
[TBL] [Abstract][Full Text] [Related]
17. Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Baglietto L; Lindor NM; Dowty JG; White DM; Wagner A; Gomez Garcia EB; Vriends AH; ; Cartwright NR; Barnetson RA; Farrington SM; Tenesa A; Hampel H; Buchanan D; Arnold S; Young J; Walsh MD; Jass J; Macrae F; Antill Y; Winship IM; Giles GG; Goldblatt J; Parry S; Suthers G; Leggett B; Butz M; Aronson M; Poynter JN; Baron JA; Le Marchand L; Haile R; Gallinger S; Hopper JL; Potter J; de la Chapelle A; Vasen HF; Dunlop MG; Thibodeau SN; Jenkins MA
J Natl Cancer Inst; 2010 Feb; 102(3):193-201. PubMed ID: 20028993
[TBL] [Abstract][Full Text] [Related]
18. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
[TBL] [Abstract][Full Text] [Related]
19. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]